Display options
Share it on

Int J Diabetes Dev Ctries. 2010 Jan;30(1):11-7. doi: 10.4103/0973-3930.60004.

Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh.

International journal of diabetes in developing countries

Kjersti Mørkrid, Liaquat Ali, Akhtar Hussain

Affiliations

  1. Institute of General Practice and Community Medicine, Department of International Health, University of Oslo. Postbox 1130 Blindern, 0318 Oslo, Norway.

PMID: 20431800 PMCID: PMC2859278 DOI: 10.4103/0973-3930.60004

Abstract

AIMS/HYPOTHESIS: The purpose of the study is to estimate the prevalence and risk factors for diabetic peripheral neuropathy (DPN) in type 2 diabetic outpatients at the BIRDEM hospital, Bangladesh.

MATERIALS AND METHODS: Type 2 diabetic outpatients, diagnosed 5-11 years prior to the investigation were randomly selected for the study. DPN was assessed using the Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS). Data about demographics, blood pressure, height, weight, waist and hip circumference, and random blood and urine samples were collected.

RESULTS: Two hundred and ninety four (139 men, 155 women) type 2 diabetic outpatients were studied. The overall DPN prevalence was 19.7 %; male (20.9%), female (18.7 %). The prevalence increased with age (from 11.1% in the 23-40 year-old group to 32.3% in the 60-80 year-old group) and duration of diabetes (from 14.1% in patients with five years to 29.2% in patients with 9-11 years duration). Age > 60 years (OR 4.2, 95% CI 1.4-12.3), low/normal WHR (OR 3.8, 95% CI 1.6-9.3), income < 800 TK (OR 3.1, 95% CI 1.1-9.3) and insulin treatment (OR 2.0, 95% CI 1.0-4.0) were independent, significant risk factors. Longer duration of diabetes (OR1.2 95% CI 1.0-1.4), and higher HbA1c (OR1.1, 95% CI 1.0-1.3) were marginally independent, significant risk factors for DPN.

CONCLUSIONS/INTERPRETATIONS: We observed a DPN prevalence of 19.7%. Higher age, low socioeconomic status, treatment with insulin, longer duration of diabetes and poor glycemic control were risk factors for DPN.

Keywords: Peripheral neuropathy; risk factors; type 2 diabetes

References

  1. Yonsei Med J. 1999 Feb;40(1):40-5 - PubMed
  2. Diabetologia. 1993 Feb;36(2):150-4 - PubMed
  3. Neurology. 1988 Jul;38(7):1161-5 - PubMed
  4. Diabetologia. 2004 Aug;47(8):1343-53 - PubMed
  5. Public Health. 2006 Mar;120(3):193-205 - PubMed
  6. Nephrol Dial Transplant. 2005 Nov;20(11):2402-7 - PubMed
  7. Eur Neurol. 2007;57(2):91-5 - PubMed
  8. Med Clin North Am. 2004 Jul;88(4):947-99, xi - PubMed
  9. Diabetes Care. 2004 May;27(5):1047-53 - PubMed
  10. Diabetes Care. 2005 Aug;28(8):1869-75 - PubMed
  11. N Engl J Med. 2005 Jan 27;352(4):341-50 - PubMed
  12. Acta Neurol Scand. 2006 Dec;114(6):384-91 - PubMed
  13. Diabet Med. 2002 Feb;19(2):99-104 - PubMed
  14. Lancet. 2005 Nov 12;366(9498):1719-24 - PubMed
  15. Med J Malaysia. 2003 Oct;58(4):533-8 - PubMed
  16. Diabetologia. 1998 Nov;41(11):1263-9 - PubMed
  17. Diabetes Metab. 2001 Sep;27(4 Pt 1):496-502 - PubMed
  18. Proc Assoc Am Physicians. 1997 Mar;109(2):181-9 - PubMed
  19. Diabetologia. 2001 Sep;44 Suppl 2:S65-71 - PubMed
  20. Diabetes Metab Res Rev. 2004 May-Jun;20 Suppl 1:S19-22 - PubMed
  21. Diabet Med. 2005 Jul;22(7):931-6 - PubMed
  22. J Assoc Physicians India. 2002 Apr;50:546-50 - PubMed
  23. Endocr J. 2004 Dec;51(6):563-7 - PubMed

Publication Types